Sign in

You're signed outSign in or to get full access.

Rafael Flores

Director at AMERENAMEREN
Board

About Rafael Flores

Rafael Flores (age 69) has served on Ameren’s board since 2015. He is a retired Senior Vice President and Chief Nuclear Officer of Luminant, with deep nuclear operations and regulatory experience; at Ameren he is independent and chairs the Nuclear, Operations and Environmental Sustainability Committee while also serving on the Audit and Risk Committee .

Past Roles

OrganizationRoleTenureCommittees/Impact
Luminant (Texas-based electric utility)Senior Vice President & Chief Nuclear Officer2009–2015Oversaw Comanche Peak Nuclear Power Plant operations; reported to nuclear oversight advisory board; represented company with NRC, INPO, NEI, and industry committees
LuminantVarious roles prior to CNOJoined 1983Progressive nuclear operations leadership

External Roles

OrganizationRoleTenureCommittees/Impact
NoneAmeren discloses no outside public company directorships for Flores

Board Governance

  • Independence: Board affirmed Flores is independent under NYSE and Ameren standards (Feb 2025) .
  • Years of service: Director since 2015 .
  • Lead Independent Director: Ellen M. Fitzsimmons (Flores not LID) .
  • Executive sessions: Independent directors meet in executive session at every regular Board meeting .
  • Attendance: Each director attended ≥83% of Board/committee meetings; average director attendance ~98% in 2024 .
CommitteeRoleMeetings in 2024
Nuclear, Operations and Environmental Sustainability (NOESC)Chair6
Audit and Risk Committee (ARC)Member10

Fixed Compensation

YearCash Retainer ($)Committee Chair Fee ($)Total Cash ($)Equity Grant ($)Total ($)
2024125,000 (standard) 20,000 (chair) 145,000 150,072 (immediately vested common stock) 295,072
2025 (program terms)125,000 (standard) 20,000 (chair) 170,000 (equity component increased)

Notes:

  • Director fees are median vs utility peers and reviewed annually; Meridian advises and found no conflicts in 2024 .
  • Directors may defer cash and/or stock awards under the Directors Deferred Compensation Plan .

Performance Compensation

Ameren’s non-management director pay does not use performance-based metrics (no STIP/PSU for directors). Equity grants are time- and immediately vested common stock, not tied to EPS/TSR-based hurdles .

Director Incentive MetricWeightTargetActual/Payout
None (directors)No performance metrics apply to director compensation

Other Directorships & Interlocks

CompanyRelationshipPotential Interlock/Conflict
NoneNo current public company boards disclosedNo interlocks identified

Expertise & Qualifications

  • Nuclear operations leadership (CNO at Luminant), direct engagement with NRC, INPO, NEI; extensive risk management and operations credentials .
  • Skills include government relations, regulatory, industry operations, compensation, and administrative experience; tenure and contributions cited by Ameren in nominating rationale .

Equity Ownership

HolderBeneficial Common SharesDeferred Stock UnitsPercent of Common StockPledging/HedgingOwnership Guidelines
Rafael Flores14,107 12,933 Stock Units under Directors Deferred Compensation Plan * (less than 1%) Company prohibits pledging/hedging for directors and employees Directors must hold ≥5x base annual cash retainer within 5 years; all non-management directors meet requirements except specified new directors—Flores is disclosed as compliant

Plan mechanics:

  • Deferred stock awards convert to Stock Units with dividend equivalents; payouts in common shares for whole units upon separation from Board, per plan terms .

Governance Assessment

  • Board effectiveness: Flores chairs NOESC, a critical committee overseeing operations, safety, environmental compliance, and climate/sustainability risks; NOESC also informs HR Committee on safety and sustainability metrics in executive incentives—this strengthens operational oversight and ESG integration .
  • Risk oversight: ARC membership places Flores within enterprise risk, controls, audit quality, and compliance oversight—beneficial given his nuclear and regulatory background .
  • Independence and conflicts: Board’s annual review found directors (not including Flores) with ordinary-course transactions below thresholds; zero Related Person Transactions in 2024; Flores remains independent—low conflict risk .
  • Attendance and engagement: Strong overall attendance (avg 98%); policy expects annual meeting attendance, met by all in 2024—supports engagement .
  • Alignment: Director stock ownership requirement (≥5x cash retainer) and anti-pledging/hedging policy support alignment and reduce red flags .
  • Compensation signals: Balanced cash ($145k including chair fee) and equity ($150k; rising to $170k in 2025 program) typical of utility peers; no performance-based director pay—neutral for pay-for-performance, but equity exposure plus ownership guidelines provide alignment .

RED FLAGS: None disclosed for Flores specifically. No pledging, no related-party transactions, and independence affirmed. Retirement policy at age 72 promotes refreshment (Flores is 69), implying near-term succession considerations for committee leadership .

Shareholder feedback:

  • Active engagement program; sustainability-focused dialogues influence committee oversight scope and reporting .
  • Prior say-on-pay approval ~95% (2024 meeting for 2023 program), indicating investor support for compensation governance broadly .